Disc Medicine (IRON) News Today $62.55 +3.00 (+5.04%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Victory Capital Management Inc. Has $10.81 Million Stock Position in Disc Medicine, Inc. (NASDAQ:IRON)Victory Capital Management Inc. lowered its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 29.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 220,014 shares of the company's stoNovember 21 at 3:17 AM | marketbeat.comWilliam Jacob Savage Sells 9,158 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockNovember 20 at 5:31 AM | insidertrades.comFY2024 EPS Estimates for Disc Medicine Lifted by AnalystNovember 20 at 2:40 AM | americanbankingnews.comCantor Fitzgerald Predicts Disc Medicine FY2024 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Cantor Fitzgerald lifted their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a research report issued to clients and investors on Wednesday, November 13th. Cantor Fitzgerald analyst K. Kluska nowNovember 18 at 2:08 AM | marketbeat.comBrokers Set Expectations for Disc Medicine FY2024 EarningsNovember 17, 2024 | americanbankingnews.comDisc Medicine Announces New Equity Sales AgreementNovember 16, 2024 | markets.businessinsider.comWedbush Has Pessimistic View of Disc Medicine Q4 EarningsNovember 16, 2024 | americanbankingnews.comLifesci Capital Expects Stronger Earnings for Disc MedicineNovember 16, 2024 | americanbankingnews.comWedbush Estimates Disc Medicine's Q4 Earnings (NASDAQ:IRON)Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Wedbush dropped their Q4 2024 earnings estimates for shares of Disc Medicine in a note issued to investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per shareNovember 15, 2024 | marketbeat.comDisc Medicine’s Promising Pipeline and Strategic Developments Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comDisc Medicine FY2024 EPS Forecast Raised by HC WainwrightDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Stock analysts at HC Wainwright upped their FY2024 EPS estimates for Disc Medicine in a research note issued on Wednesday, November 13th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings of ($3.88) per share for theNovember 15, 2024 | marketbeat.comDisc Medicine FY2024 EPS Estimate Boosted by Leerink PartnrsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a note issued to investors on Tuesday, November 12th. Leerink Partnrs analyst T. Smith now expects that the company will pNovember 15, 2024 | marketbeat.comFY2024 EPS Estimate for Disc Medicine Increased by AnalystDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at Lifesci Capital raised their FY2024 earnings per share (EPS) estimates for shares of Disc Medicine in a report released on Tuesday, November 12th. Lifesci Capital analyst R. Katkhuda now anticipates that the company will post earningsNovember 15, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of "Buy" by BrokeragesNovember 15, 2024 | americanbankingnews.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have received a consensus recommendation of "Buy" from the ten ratings firms that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has issued a strong buy recoNovember 15, 2024 | marketbeat.comWedbush Has Optimistic View of Disc Medicine FY2028 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Wedbush upped their FY2028 earnings estimates for Disc Medicine in a research report issued to clients and investors on Tuesday, November 12th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of $7.04 per share forNovember 14, 2024 | marketbeat.comDisc Medicine (IRON) Receives a Buy from Stifel NicolausNovember 14, 2024 | markets.businessinsider.comDisc Medicine (IRON) Gets a Buy from Morgan StanleyNovember 14, 2024 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPSDisc Medicine (NASDAQ:IRON - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($1.04) by $0.15.November 13, 2024 | marketbeat.comDisc Medicine to Participate in Upcoming Investor ConferencesNovember 13, 2024 | globenewswire.comDisc Medicine Inc Ordinary SharesNovember 12, 2024 | morningstar.comDisc Medicine’s Strong Financial Position and Promising Clinical Developments Drive Buy RatingNovember 12, 2024 | markets.businessinsider.comDisc Medicine Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | markets.businessinsider.comDisc Medicine Secures $200M Financing for Hematology PipelineNovember 9, 2024 | markets.businessinsider.comDisc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.November 8, 2024 | globenewswire.comLeerink Partnrs Expects Weaker Earnings for Disc MedicineDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for Disc Medicine in a research note issued on Monday, November 4th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($6.2November 7, 2024 | marketbeat.comDisc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual MeetingNovember 6, 2024 | finance.yahoo.comDisc Medicine price target raised to $70 from $62 at ScotiabankNovember 6, 2024 | markets.businessinsider.comScotiabank Reaffirms Their Buy Rating on Disc Medicine (IRON)November 6, 2024 | markets.businessinsider.comWedbush Has Strong Outlook for Disc Medicine FY2024 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Stock analysts at Wedbush upped their FY2024 earnings per share estimates for shares of Disc Medicine in a research note issued on Monday, November 4th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($3.92) pNovember 6, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Director William Richard White Sells 7,136 SharesNovember 6, 2024 | insidertrades.comDisc Medicine (NASDAQ:IRON) Stock Price Up 7% - Here's WhyDisc Medicine (NASDAQ:IRON) Trading Up 7% - Here's What HappenedNovember 5, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $70.00 price target on shares of Disc Medicine in a report on Tuesday.November 5, 2024 | marketbeat.comDisc Medicine upgraded to Overweight from Equal Weight at Morgan StanleyNovember 5, 2024 | markets.businessinsider.comDisc Medicine (IRON) Gets a Buy from Wells FargoNovember 5, 2024 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Upgraded to Overweight at Morgan StanleyMorgan Stanley raised shares of Disc Medicine from an "equal weight" rating to an "overweight" rating and set a $85.00 target price on the stock in a research note on Tuesday.November 5, 2024 | marketbeat.comDisc Medicine’s Prospects Brighten with Accelerated Approval Potential for BitopertinNovember 5, 2024 | markets.businessinsider.comWedbush Reaffirms Outperform Rating for Disc Medicine (NASDAQ:IRON)Wedbush reissued an "outperform" rating and set a $75.00 price objective (up previously from $60.00) on shares of Disc Medicine in a report on Monday.November 4, 2024 | marketbeat.comDisc Medicine upgraded at Raymond James as bitopertin ‘uber bull case plays out’November 4, 2024 | markets.businessinsider.comDisc Medicine Shares Rise After Positive Feedback From FDANovember 4, 2024 | marketwatch.comDisc teases potential NDA for rare skin disorder drugNovember 4, 2024 | finance.yahoo.comDisc Medicine (NASDAQ:IRON) Shares Gap Up - Should You Buy?Disc Medicine (NASDAQ:IRON) Shares Gap Up - Should You Buy?November 4, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Rating Increased to Strong-Buy at Raymond JamesRaymond James raised Disc Medicine from an "outperform" rating to a "strong-buy" rating and boosted their price target for the stock from $66.00 to $110.00 in a research report on Monday.November 4, 2024 | marketbeat.comDisc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated ApprovalNovember 4, 2024 | globenewswire.comIron supplements may boost brain development in children with HIVNovember 2, 2024 | msn.comDisc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)November 1, 2024 | globenewswire.comStudy demonstrates efficacy of iron supplements for children living with HIVNovember 1, 2024 | msn.comDisc Medicine, Inc. (NASDAQ:IRON) Short Interest Down 6.9% in OctoberDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 1,480,000 shares, a decrease of 6.9% from the September 30th total of 1,590,000 shares. Based on an average daily trading volume, of 215,400 shares, the days-to-cover ratio is currently 6.9 days. Approximately 9.5% of the shares of the stock are short sold.October 31, 2024 | marketbeat.comDisc Medicine’s Promising Anemia Treatment Drives Buy RatingOctober 28, 2024 | markets.businessinsider.comDisc Medicine (IRON) Receives a Buy from ScotiabankOctober 28, 2024 | markets.businessinsider.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼0.660.45▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼345▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ardelyx News Landsea Homes News Quantum-Si News Puma Biotechnology News PolyPid News Legend Biotech News Elanco Animal Health News Blueprint Medicines News Nuvalent News Cytokinetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
